0:00-9:56
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
megaphone.fm/adchoices
megaphone.fm